Author Question: A patient who has been diagnosed with human immune deficiency syndrome is given ganciclovir ... (Read 25 times)

penza

  • Hero Member
  • *****
  • Posts: 1,022
A patient who has been diagnosed with human immune deficiency syndrome is given ganciclovir (Cytovene) to prevent cytomegalovirus. The patient develops granulocytopenia.
 
  How long will it take for the granulocytes to regenerate after the ganciclovir is discontinued? A) 5 days
  B) 7 days
  C) 10 days
  D) 14 days

Question 2

A 12-year-old boy has been diagnosed with acute otitis externa. The patient's mother has asked if oral medications might be more effective than ear drops.
 
  The nurse should respond in the knowledge that systemic medications for the treatment of otitis externa are only indicated in what circumstances? A) The infection is accompanied by ear discharge.
  B) The patient is allergic to penicillins.
  C) The patient is unable to self-administer ear drops.
  D) A deep tissue infection develops.



nathang24

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

B
Feedback:
Ganciclovir causes granulocytopenia and thrombocytopenia in 20 to 40 of recipients, often during the first 2 weeks of therapy. If severe bone marrow depression occurs, ganciclovir should be discontinued; recovery usually occurs within a week of stopping the drug. Five days after discontinuing the drug is too soon to see a change in granulocytopenia. Ten to fourteen days is too long for change to occur. It should have occurred within 1 week.

Answer to Question 2

D
Feedback:
For acute otitis externa, use of topical agents, as opposed to systemic agents, is more common. Systemic medications are indicated only if a deep tissue infection develops outside the external canal or if immunocompromised status is an issue. Allergy status, ability to self-administer, and the presence or discharge are not indications for systemic antibiotics.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

The average office desk has 400 times more bacteria on it than a toilet.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Eat fiber! A diet high in fiber can help lower cholesterol levels by as much as 10%.

For a complete list of videos, visit our video library